17 related articles for article (PubMed ID: 1335076)
1. Beta-hydroxyphosphonate ribonucleoside analogues derived from 4-substituted-1,2,3-triazoles as IMP/GMP mimics: synthesis and biological evaluation.
Nguyen Van T; Hospital A; Lionne C; Jordheim LP; Dumontet C; Périgaud C; Chaloin L; Peyrottes S
Beilstein J Org Chem; 2016; 12():1476-86. PubMed ID: 27559400
[TBL] [Abstract][Full Text] [Related]
2. Mapping adenosine cyclic 3',5'-phosphate binding sites on type I and type II adenosine cyclic 3',5'-phosphate dependent protein kinases using ribose ring and cyclic phosphate ring analogues of adenosine cyclic 3',5'-phosphate.
Yagura TS; Miller JP
Biochemistry; 1981 Feb; 20(4):879-87. PubMed ID: 6260142
[TBL] [Abstract][Full Text] [Related]
3. Effect of some new cAMP analogs on cAMP-dependent protein kinase isoenzymes.
Szücs K; Sági G; Vereb G
Int J Biochem; 1992 Jun; 24(6):915-21. PubMed ID: 1319355
[TBL] [Abstract][Full Text] [Related]
4. Binding of adenosine 3',5'-monophosphate dependent protein kinase regulatory subunit to immobilized cyclic nucleotide derivatives.
Dills WL; Beavo JA; Bechtel PJ; Myers KR; Sakai LJ; Krebs EG
Biochemistry; 1976 Aug; 15(17):3724-31. PubMed ID: 182216
[TBL] [Abstract][Full Text] [Related]
5. The 3'-amido and 5'-amido analogues of adenosine 3':5'-monophosphate; interaction with cAMP-specific proteins.
Panitz N; Rieke E; Morr M; Wagner KG; Roesler G; Jastorff B
Eur J Biochem; 1975 Jul; 55(2):415-22. PubMed ID: 172331
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Sp-5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole- 3',5'-monophosphorothioate (Sp-5,6-DCl-cBiMPS) as a potent and specific activator of cyclic-AMP-dependent protein kinase in cell extracts and intact cells.
Sandberg M; Butt E; Nolte C; Fischer L; Halbrügge M; Beltman J; Jahnsen T; Genieser HG; Jastorff B; Walter U
Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):521-7. PubMed ID: 1659381
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and enzymatic activity of some new purine ring system analogues of adenosine 3',5'-cyclic monophosphate.
Sági G; Szũcs K; Vereb G; Otvös L
J Med Chem; 1992 Nov; 35(24):4549-56. PubMed ID: 1335076
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the solid-phase combinatorial synthetic strategies for the quinoxaline, quinazoline and benzimidazole based privileged structures.
Kamal A; Reddy KL; Devaiah V; Shankaraiah N; Rao MV
Mini Rev Med Chem; 2006 Jan; 6(1):71-89. PubMed ID: 16457633
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
